The Peptide Directory

Thymosin alpha-1 vs TB-500: Which Is Right for You?

Despite similar names they are unrelated peptides. Thymosin alpha-1 (thymalfasin, Zadaxin) is a 28-amino-acid immune peptide approved in a number of countries outside the US for hepatitis B and as an immune adjuvant; TB-500 is a synthetic version or fragment of thymosin beta-4, studied for tissue repair and never approved.

Side-by-side comparison

Thymosin alpha-1TB-500
Parent proteinProthymosin alphaThymosin beta-4 (43 aa)
Main research areaImmune modulationTissue repair, actin binding
ApprovalApproved outside the US (Zadaxin)None
FDA statusNot FDA-approvedNot FDA-approved
Sports anti-dopingNot specifically listedProhibited (WADA S2)

Complete comparison (2026)

Key takeaways

  1. "Thymosin" names a family of unrelated peptides.
  2. Only thymosin alpha-1 has approvals anywhere.
  3. TB-500 is prohibited in sport.

What are Thymosin alpha-1 and TB-500?

Thymosin alpha-1 (thymalfasin, Zadaxin) is a 28-amino-acid thymic peptide approved in some countries for hepatitis B; it is not FDA-approved.

TB-500 is a synthetic peptide marketed as a version or fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein that binds actin and is involved in cell migration and wound repair; it is not FDA-approved.

Mechanism differences

Thymosin alpha-1 is reported to enhance T-cell function. Thymosin beta-4 binds actin and was studied for wound and corneal healing; "TB-500" products may contain the full peptide or a short fragment.

Effectiveness

Thymosin alpha-1 has randomized trials in chronic hepatitis B and as a vaccine adjuvant, with mixed results. Thymosin beta-4 was tested in small trials of eye drops for dry eye and corneal injury; TB-500 as sold has no human trials.

Side effect profiles

Thymosin alpha-1 trials reported mild injection-site discomfort. Human safety data for TB-500 products are absent.

Dosing & administration

No US label exists. We don't publish doses.

Cost

Verified TB-500 per-mg prices are on our price comparison.

FDA & regulatory status

Neither is FDA-approved; "research use only" products are not for human use.

Who should choose which

There is no evidence-based reason to choose either for personal use.

What the evidence does not show

  • That TB-500 products match the thymosin beta-4 used in trials.

Frequently asked questions

Is thymosin alpha-1 the same as TB-500?

No. They are different peptides from different parent proteins with different functions.

Where is thymosin alpha-1 approved?

As Zadaxin it is approved in a number of countries outside the US, mainly for hepatitis B; it is not FDA-approved.

Is TB-500 banned in sport?

Yes. WADA prohibits thymosin beta-4 and its derivatives.

References

  1. Thymalfasin in the treatment of hepatitis B and C, Ann N Y Acad Sci (2010), PMID 20536462
  2. beta-Thymosins, Ann N Y Acad Sci (2007), PMID 17468232
  3. Thymosin beta 4 and the eye: the journey from bench to bedside, Expert Opin Biol Ther (2018), PMID 30063853
  4. July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee, FDA (2026)
  5. FDA Panel Backs 6 Peptides for Compounding, AJMC (2026)
  6. Thymosin beta-4 — PubChem compound summary (CID 45382195), PubChem

Find a clinic

Our clinic directory lists only clinics whose address and services we confirmed on their own websites, with the date we checked.

Browse the clinic directory